Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

(2013) Fred D. Lublin et al.   ANNALS OF NEUROLOGY

The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry

(2013) Molly Nickerson et al.   BMC Neurology

Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination

(2013) Abdolmohamad Rostami et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Piet Mondrian’s trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011

(2013) Lawrence Steinman et al.   Multiple Sclerosis Journal

Multiple Sclerosis, Relapses, and the Mechanism of Action of Adrenocorticotropic Hormone

(2013) Amy Perrin Ross et al.   Frontiers in Neurology

Cladribine tablets for the treatment of relapsing–remitting multiple sclerosis

(2012) Giancarlo Comi et al.   EXPERT OPINION ON PHARMACOTHERAPY

Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis

(2012) Luca Prosperini et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis

(2012) B. G. Arnason et al.   Multiple Sclerosis Journal

Neuroprotection and repair in multiple sclerosis

(2012) Robin J. M. Franklin et al.   Nature Reviews Neurology

Treatment of Acute Relapses in Multiple Sclerosis

(2012) Regina Berkovich   Neurotherapeutics

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

(2012) Ralf Gold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Beneficial Plasma Exchange Response in Central Nervous System Inflammatory Demyelination

(2011) Setty M. Magaña   ARCHIVES OF NEUROLOGY

Effects of acute relapses on neuropsychological status in multiple sclerosis patients

(2011) S. A. Morrow et al.   JOURNAL OF NEUROLOGY

Immunologic Aspects of Multiple Sclerosis

(2011) Sridhar Boppana et al.   MOUNT SINAI JOURNAL OF MEDICINE

The renaissance of corticotropin therapy in proteinuric nephropathies

(2011) Rujun Gong   Nature Reviews Nephrology

Treatment of Multiple Sclerosis Exacerbations

(2011) Pavle Repovic et al.   NEUROLOGIC CLINICS

Age and disability accumulation in multiple sclerosis

(2011) A. Scalfari et al.   NEUROLOGY

High prevalence of anti-α-crystallin antibodies in multiple sclerosis: correlation with severity and activity of disease

(2010) M. A. Agius et al.   ACTA NEUROLOGICA SCANDINAVICA

Disability Progression in a Clinical Trial of Relapsing-Remitting Multiple Sclerosis

(2010) Richard A. Rudick et al.   ARCHIVES OF NEUROLOGY

The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability

(2010) Antonio Scalfari et al.   BRAIN

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis

(2010) J. M. Fletcher et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Trafficking of immune cells in the central nervous system

(2010) Emma H. Wilson et al.   JOURNAL OF CLINICAL INVESTIGATION

Early cognitive impairment in multiple sclerosis predicts disability outcome several years later

(2010) Mathilde Deloire et al.   Multiple Sclerosis Journal

Measuring disability in relapsing-remitting MS

(2010) R. A. Rudick et al.   NEUROLOGY

Surrogate endpoints for EDSS worsening in multiple sclerosis: A meta-analytic approach

(2010) M. P. Sormani et al.   NEUROLOGY

Management of acute exacerbations in multiple sclerosis

(2009) AlexD Rae-Grant et al.   Annals of Indian Academy of Neurology

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach

(2009) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis

(2009) Massimiliano Calabrese et al.   ARCHIVES OF NEUROLOGY

Role of the innate immune system in the pathogenesis of multiple sclerosis

(2009) Roopali Gandhi et al.   JOURNAL OF NEUROIMMUNOLOGY

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

(2009) Ludwig Kappos et al.   LANCET NEUROLOGY

Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS

(2009) L Strober et al.   Multiple Sclerosis Journal

Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit

(2009) WM Carroll   Multiple Sclerosis Journal

Accumulation of cortical lesions in MS: relation with cognitive impairment

(2009) SD Roosendaal et al.   Multiple Sclerosis Journal

Measures in the first year of therapy predict the response to interferon β in MS

(2009) J Río et al.   Multiple Sclerosis Journal

Impact of multiple sclerosis relapses on progression diminishes with time

(2009) H. Tremlett et al.   NEUROLOGY

Homogeneity of active demyelinating lesions in established multiple sclerosis

(2008) Esther C. W. Breij et al.   ANNALS OF NEUROLOGY

Astrocytes in multiple sclerosis: A product of their environment

(2008) A. Nair et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Contribution of relapses to disability in multiple sclerosis

(2008) C. Hirst et al.   JOURNAL OF NEUROLOGY

Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients

(2008) J Río et al.   Multiple Sclerosis Journal

Immunologic Mechanisms of Multiple Sclerosis

(2008) Elliot M. Frohman et al.   NEUROIMAGING CLINICS OF NORTH AMERICA